Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Recruiting 1 Completed 1

Sponsor Class

OTHER 23 INDUSTRY 3 OTHER_GOV 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 107 Neoplasms 79 Colorectal Neoplasms 54 Stomach Neoplasms 29 Uterine Cervical Neoplasms 28 Lung Neoplasms 27 Rectal Neoplasms 25 Prostatic Neoplasms 25 Colonic Neoplasms 24 Polycystic Ovary Syndrome 22 Pancreatic Neoplasms 22 Head and Neck Neoplasms 17 Endometrial Neoplasms 17 Carcinoma, Non-Small-Cell Lung 16 Carcinoma, Hepatocellular 16 Pain 15 Neoplasm Metastasis 15 Motor Activity 15 Esophageal Neoplasms 15 Ovarian Neoplasms 13 Urinary Bladder Neoplasms 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Pain, Postoperative 10 Melanoma 10 Lymphoma 10 Thyroid Neoplasms 9 Pilonidal Sinus 9 Multiple Myeloma 9 Gastrointestinal Neoplasms 9 Sarcopenia 8

Interventions

Cell- and Tissue-Based Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × OTHER_GOV × Erectile Dysfunction × Clear all

NCT01089387 2025-12-04

INSTIN

Institut National de la Santé Et de la Recherche Médicale, France

Phase 1/2 Completed

Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡